United Therapeutics (UTHR) Work In Process (2010 - 2020)

United Therapeutics has disclosed Work In Process across 11 years of filings, most recently posting $28.1 million for Q1 2020.

• Work In Process for Q1 2020 came in at $28.1 million, up 6.84% year-over-year; the trailing twelve-month figure through Mar 2020 was $28.1 million (up 6.84% YoY), and the FY2019 annual result was $29.1 million, up 3.93% from the prior year.
• Work In Process came in at $28.1 million for Q1 2020 at United Therapeutics, down from $29.1 million in the prior quarter.
• In the past five years, Work In Process ranged from a high of $29.8 million in Q3 2019 to a low of $22.9 million in Q1 2017.
• The 5-year median for Work In Process is $26.2 million (2016), against an average of $26.2 million.
• Across the five-year window, Work In Process increased 21.29% in 2016 and declined 13.33% in 2017, its largest moves.
• United Therapeutics' Work In Process stood at $24.9 million in 2016, then dropped by 3.21% to $24.1 million in 2017, then climbed by 16.18% to $28.0 million in 2018, then climbed by 3.93% to $29.1 million in 2019, then decreased by 3.44% to $28.1 million in 2020.
• The last three Work In Process figures came in at $28.1 million (Q1 2020), $29.1 million (Q4 2019), and $29.8 million (Q3 2019), per Business Quant data.